Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
Academic Research Consortium
bleeding
female sex
percutaneous coronary intervention
vascular access
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
15 06 2021
15 06 2021
Historique:
pubmed:
9
6
2021
medline:
3
11
2021
entrez:
8
6
2021
Statut:
ppublish
Résumé
Background Female sex was not included among the high bleeding risk (HBR) criteria by the Academic Research Consortium (ARC) as it remains unclear whether it constitutes an HBR condition after percutaneous coronary intervention. We investigated whether female sex associates with HBR and assessed the performance of ARC HBR criteria separately in women and men. Methods and Results Among all consecutive patients undergoing percutaneous coronary intervention between 2009 and 2018, bleeding occurrences up to 1 year were prospectively collected and centrally adjudicated. All but one of the originally defined ARC HBR criteria were assessed, and the ARC HBR score generated accordingly. Among 16 821 patients, 25.6% were women. Compared with men, women were older and had lower creatinine clearance and hemoglobin values. After adjustment, female sex was independently associated with access-site (adjusted hazard ratio, 2.14; 95% CI, 1.22-3.74;
Identifiants
pubmed: 34098740
doi: 10.1161/JAHA.121.021965
pmc: PMC8477884
doi:
Banques de données
ClinicalTrials.gov
['NCT02241291']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e021965Références
Circ Cardiovasc Interv. 2010 Apr;3(2):140-7
pubmed: 20332382
PLoS One. 2018 Sep 4;13(9):e0203325
pubmed: 30180201
J Am Heart Assoc. 2014 Feb 07;3(1):e000523
pubmed: 24510115
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):675-683
pubmed: 31115141
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115
pubmed: 27036918
Am J Cardiol. 2014 Jun 15;113(12):2002-6
pubmed: 24793670
JACC Cardiovasc Interv. 2018 Jan 8;11(1):36-50
pubmed: 29301646
J Thromb Thrombolysis. 2013 Jul;36(1):84-90
pubmed: 23239168
JAMA Cardiol. 2020 Aug 1;5(8):939-947
pubmed: 32432718
JACC Cardiovasc Interv. 2014 Aug;7(8):857-67
pubmed: 25147030
Circulation. 2019 Jul 16;140(3):240-261
pubmed: 31116032
JACC Cardiovasc Interv. 2015 Apr 20;8(4):505-12
pubmed: 25907080
Cardiovasc Ther. 2017 Aug;35(4):
pubmed: 28459500
Eur Heart J. 2017 Mar 14;38(11):804-810
pubmed: 28363222
J Am Heart Assoc. 2021 Jun 15;10(12):e021965
pubmed: 34098740
Circulation. 2012 Oct 30;126(18):2190-9
pubmed: 22988009
Am Heart J. 2015 Oct;170(4):695-705.e5
pubmed: 26386793
J Am Heart Assoc. 2015 Jul 14;4(7):
pubmed: 26175358
Eur Heart J. 2020 Oct 7;41(38):3743-3749
pubmed: 33029615
Eur Heart J. 2014 Jun 14;35(23):1541-50
pubmed: 24682844
Lancet. 2017 Mar 11;389(10073):1025-1034
pubmed: 28290994
J Am Heart Assoc. 2020 Apr 7;9(7):e014611
pubmed: 32223396
Circulation. 2007 May 1;115(17):2344-51
pubmed: 17470709
Eur Heart J. 2018 Jan 14;39(3):213-260
pubmed: 28886622
J Am Coll Cardiol. 2016 May 17;67(19):2224-2234
pubmed: 27079334
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):359-68
pubmed: 25115966
Circulation. 2018 Jun 12;137(24):2635-2650
pubmed: 29891620
JACC Cardiovasc Interv. 2012 Nov;5(11):1108-16
pubmed: 23174634
J Interv Cardiol. 2018 Jun;31(3):345-352
pubmed: 29490431
Circulation. 2009 Apr 14;119(14):1873-82
pubmed: 19332461